Dr. Stephan Polterauer, MD
Claim this profileAKH - Medizinische Universitat Wien
Area of expertise
Endometrial Cancer
Stephan Polterauer, MD has run 2 trials for Endometrial Cancer. Some of their research focus areas include:
Cervical Cancer
Stephan Polterauer, MD has run 1 trial for Cervical Cancer. Some of their research focus areas include:
Clinical Trials Stephan Polterauer, MD is currently running
Navtemadlin
for Endometrial Cancer
This trial tests navtemadlin to see if it can prevent endometrial cancer from returning in patients who responded well to chemotherapy. The study will check the safety and effectiveness of different doses of the drug.
Recruiting
0 awards
Phase 2 & 3
Outcomes
for Endometrial Cancer
This study evaluates whether isolated tumor cells in the first lymph nodes near the tumor can tell researchers something important about the future of patients with a certain type of endometrial (uterine) cancer.
Recruiting
1 award
N/A
5 criteria
More about Stephan Polterauer, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Stephan Polterauer, MD has experience with
- Gemcitabine
- Irinotecan
- Pemetrexed
- Tisotumab Vedotin
- Topotecan
- Vinorelbine
Breakdown of trials Stephan Polterauer, MD has run
Endometrial Cancer
Cervical Cancer
Ovarian Cancer
Endometrial Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Stephan Polterauer, MD specialize in?
Stephan Polterauer, MD focuses on Endometrial Cancer and Cervical Cancer. In particular, much of their work with Endometrial Cancer has involved TP53 positive patients, or patients who are Stage IV.
Is Stephan Polterauer, MD currently recruiting for clinical trials?
Yes, Stephan Polterauer, MD is currently recruiting for 2 clinical trials in Vienna Other. If you're interested in participating, you should apply.
Are there any treatments that Stephan Polterauer, MD has studied deeply?
Yes, Stephan Polterauer, MD has studied treatments such as Gemcitabine, Irinotecan, Pemetrexed.
What is the best way to schedule an appointment with Stephan Polterauer, MD?
Apply for one of the trials that Stephan Polterauer, MD is conducting.
What is the office address of Stephan Polterauer, MD?
The office of Stephan Polterauer, MD is located at: AKH - Medizinische Universitat Wien, Vienna, Other 1090 Austria. This is the address for their practice at the AKH - Medizinische Universitat Wien.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.